Plato Investment Management LTD Exelixis, Inc. Call Options Transaction History
Plato Investment Management LTD
- $1.19 Trillion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding EXEL
# of Institutions
611Shares Held
257MCall Options Held
1.57MPut Options Held
730K-
Black Rock Inc. New York, NY33.5MShares$1.46 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA28.7MShares$1.25 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA22.5MShares$985 Million4.78% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny14.8MShares$648 Million0.88% of portfolio
-
State Street Corp Boston, MA11.8MShares$515 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $14.1B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...